Genetic Test predicts when chemo benefit to spread to lymph nodes

[tousled1]

LOS ANGELES, Dec 13 (Reuters) - Genomic Health Inc (GHDX.O: Quote (http://www.reuters.com/stocks/quote?symbol=GHDX.O), Profile (http://www.reuters.com/stocks/companyProfile?symbol=GHDX.O), Research (http://www.reuters.com/stocks/researchReports?symbol=GHDX.O)) said on Thursday its genetic test can help predict when chemotherapy is likely to benefit women with breast cancer that has spread to the lymph nodes

Read full article:

http://www.reuters.com/article/companyNewsAndPR/idUSN1365041720071213